Velan Capital Investment Management L.P. is an investment fund managing more than $175 billion ran by Alyssa Romano. There are currently 17 companies in Mrs. Romano’s portfolio. The largest investments include Alimera Sciences and Jasper Therapeutics Inc, together worth $108 billion.
As of 7th August 2024, Velan Capital Investment Management L.P.’s top holding is 13,608,533 shares of Alimera Sciences currently worth over $75.7 billion and making up 43.3% of the portfolio value.
Relative to the number of outstanding shares of Alimera Sciences, Velan Capital Investment Management L.P. owns less than 0.3% of the company.
In addition, the fund holds 1,471,904 shares of Jasper Therapeutics Inc worth $32.5 billion, whose value fell approximately 0.1% in the past six months.
The third-largest holding is Heron Therapeutics Inc worth $24.5 billion and the next is Praxis Precision Medicines I worth $14.5 billion, with 350,666 shares owned.
Currently, Velan Capital Investment Management L.P.'s portfolio is worth at least $175 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Velan Capital Investment Management L.P. office and employees reside in Alpharetta, Georgia. According to the last 13-F report filed with the SEC, Alyssa Romano serves as the Chief Financial Officer at Velan Capital Investment Management L.P..
In the most recent 13F filing, Velan Capital Investment Management L.P. revealed that it had opened a new position in
Skye Bioscience Inc and bought 422,142 shares worth $3.38 billion.
The investment fund also strengthened its position in Rezolute Inc by buying
400,000 additional shares.
This makes their stake in Rezolute Inc total 800,000 shares worth $3.44 billion.
On the other hand, there are companies that Velan Capital Investment Management L.P. is getting rid of from its portfolio.
Velan Capital Investment Management L.P. closed its position in Adma Biologics Inc on 14th August 2024.
It sold the previously owned 1,528,601 shares for $10.1 billion.
Alyssa Romano also disclosed a decreased stake in OptiNose Inc by 0.2%.
This leaves the value of the investment at $2.59 billion and 2,492,830 shares.
The two most similar investment funds to Velan Capital Investment Management L.P. are Aurora Investment Counsel and Castleview Partners. They manage $175 billion and $175 billion respectively.
Velan Capital Investment Management L.P.’s portfolio is diversified across 3 sectors.
Currently, their heaviest sector is Health Care — making up 64.1% of
the total portfolio value.
The fund focuses on investments in the United States as
47.1% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
35% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $104 million.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Alimera Sciences Inc. |
No change
13,608,533
|
$75,663,443,000 | 43.35% |
| Jasper Therapeutics Inc |
No change
1,471,904
|
$32,547,896,000 | 18.65% |
| Heron Therapeutics Inc |
No change
6,986,744
|
$24,453,604,000 | 14.01% |
| Praxis Precision Medicines I |
No change
350,666
|
$14,503,546,000 | 8.31% |
| Adma Biologics Inc |
Closed
1,528,601
|
$10,088,767,000 | |
| Tourmaline Bio Inc |
No change
319,080
|
$4,103,369,000 | 2.35% |
| Inspire Med Sys Inc |
Closed
18,000
|
$3,866,220,000 | |
| TELA Bio, Inc. |
No change
746,087
|
$3,506,609,000 | 2.01% |
| Rezolute Inc |
100.00%
800,000
|
$3,440,000,000 | 1.97% |
| Skye Bioscience Inc |
Opened
422,142
|
$3,381,357,000 | 1.94% |
| OptiNose Inc |
16.94%
2,492,830
|
$2,592,543,000 | 1.49% |
| Context Therapeutics Inc |
Opened
1,290,323
|
$2,587,098,000 | 1.48% |
| Aquestive Therapeutics Inc |
Closed
600,000
|
$2,556,000,000 | |
| InspireMD Inc |
No change
904,029
|
$2,255,824,000 | 1.29% |
| Outlook Therapeutics Inc |
50.58%
247,084
|
$1,823,480,000 | 1.04% |
| Geron Corp. |
Closed
500,000
|
$1,650,000,000 | |
| Elevation Oncology Inc |
20.11%
597,299
|
$1,612,707,000 | 0.92% |
| Milestone Pharmaceuticals In |
Closed
650,000
|
$1,163,500,000 | |
| Protara Therapeutics Inc |
Opened
480,000
|
$998,400,000 | 0.57% |
| Envveno Medical Corporation |
Closed
172,235
|
$936,958,000 | |
| Kiora Pharmaceuticals Inc |
Closed
1,100,000
|
$776,600,000 | |
| Kiora Pharmaceuticals Inc |
Opened
122,223
|
$513,337,000 | 0.29% |
| X4 Pharmaceuticals, Inc. |
Opened
659,020
|
$382,232,000 | 0.22% |
| ASLAN Pharmaceuticals Ltd |
No change
625,000
|
$187,500,000 | 0.11% |
| No transactions found | |||
| Showing first 500 out of 24 holdings | |||